The Immune System – News and Features
News
Genedata Expands Collaboration with HepatoSys
Swiss-based computational biology provider Genedata AG announced a three-year expansion of their collaboration with the HepatoSys research network.
News
Woven Scaffolds Could Improve Cartilage Repair
Duke University researchers have created a three-dimensional fabric scaffold that could improve the ability of physicians to repair damaged joints with the patient's own stem cells.
News
Siemens to Emphasize Emerging Fields of Oncology, Neurology Biomarkers with New Research Facility
Siemens’ Molecular Imaging research facility is dedicated to the development of molecular imaging biomarkers for identifying debilitating diseases at their earliest stages.
News
UCLA Researchers Discover Genes Linked to Lymphoma, Opening Way for New Targeted Drugs
Researchers funded by The Leukemia & Lymphoma Society used genetically engineered mice to accurately mimic human B-cell cancers.
News
abc Technologies - Automation Beyond Chemistry
Prominent scientists gathered in Basel to discuss new perspectives and emerging technologies across a broad range of industries.
News
BioE®, Inc. and M. D. Anderson Cancer Center Form Research Partnership
BioE and M. D. Anderson collaborate to determine the utility of Multi-Lineage Progenitor Cell™ as an anti-tumor protein delivery vehicle.
News
Stem Cell Marker Identified in Head and Neck Cancer
University of Michigan and Stanford University researchers report first evidence of cancer stem cells in head and neck tumors.
News
Scientists Discover New Gene Associated with Crohn’s Disease
Researchers at Applied Biosystems and University of Keil identify a gene to support the role of abnormal immune response in Crohn’s disease.
News
QuantRx® Biomedical Receives Grant and Incentives from Portland Development Commission for New R&D Facility
The PDC allocates funds to a 7,000 square foot R&D facility in Portland for development and manufacturing of QuantRx lateral flow devices.
News
DanioLabs and Senexis Announce Collaboration on Ageing Related Diseases
The combination of the two approaches will offer an opportunity to develop molecules having disease-modifying therapies for Alzheimer’s disease.
Advertisement